|
PPP3CB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.29129945519924E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.18499998491961E-09 |
| Normal-vs-Stage2 |
3.439300E-03 |
| Normal-vs-Stage3 |
5.92310001046314E-09 |
| Normal-vs-Stage4 |
1.12720000000621E-07 |
| Stage1-vs-Stage2 |
4.093400E-01 |
| Stage1-vs-Stage3 |
1.655800E-01 |
| Stage1-vs-Stage4 |
5.264100E-02 |
| Stage2-vs-Stage3 |
1.189390E-01 |
| Stage2-vs-Stage4 |
7.331600E-02 |
| Stage3-vs-Stage4 |
7.419000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.51299997372701E-10 |
| Normal-vs-AfricanAmerican |
3.78830000036245E-07 |
| Normal-vs-Asian |
1.180130E-03 |
| Caucasian-vs-AfricanAmerican |
2.750400E-01 |
| Caucasian-vs-Asian |
8.486000E-01 |
| AfricanAmerican-vs-Asian |
5.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81894516010561E-12 |
| Normal-vs-Female |
1.95830000004893E-06 |
| Male-vs-Female |
3.296200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.06809999955715E-07 |
| Normal-vs-Extreme_Weight |
2.93259971861914E-10 |
| Normal-vs-Obese |
3.34550000036238E-07 |
| Normal-vs-Extreme_Obese |
5.79099999999944E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.836200E-01 |
| Normal_Weight-vs-Obese |
4.947000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.026800E-01 |
| Extreme_Weight-vs-Obese |
2.932000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.967000E-01 |
| Obese-vs-Extreme_Obese |
3.961200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.21299999999991E-06 |
| Normal-vs-Age(41-60Yrs) |
1.93370000012294E-08 |
| Normal-vs-Age(61-80Yrs) |
1.85329973589887E-10 |
| Normal-vs-Age(81-100Yrs) |
2.73539999540162E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.077200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.649200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.340400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.682200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.584300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.487240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.13250000488563E-08 |
| Normal-VS-Type2 PRCC |
1.40170097751025E-11 |
| Normal-VS-KIRP CIMP |
8.48380000029181E-07 |
| Normal-VS-Unclassified PRCC |
2.62160000041867E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.701800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.198000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.618600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.857000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.686400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.972000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.46229728115577E-11 |
| Normal-vs-N1 |
4.30210311819224E-11 |
| Normal-vs-N2 |
3.837000E-04 |
| N0-vs-N1 |
4.211000E-01 |
| N0-vs-N2 |
6.844400E-01 |
| N1-vs-N2 |
8.966000E-01 |
|
|
